Our Unique Offering
Nucleus Network is the only Phase 1 clinical research organization in the world to have Phase 1 facilities located in Australia and the USA. We are Australia’s largest Phase 1 clinical research organization and one of the few specialized units in the USA capable of delivering Phase 1 hepatic and renal clinical trials.
Nucleus Network is uniquely positioned to help administer your clinical trial with our four key advantages:
Each of our Phase 1 facilities have focused areas of specialization and extensive internal and external capabilities to support the complex requirements of Phase 1 clinical trials.
Our Phase 1 facilities are supported by a highly trained and dedicated team of medical personnel (FRACP), including clinical pharmacologists, oncologists, nephrologists and infectious disease physicians.
Our Australian Phase 1 facilities are strategically co-located within prominent Hospitals and our USA Phase 1 facility benefits from co-locating within a Life Sciences and Biomedical Research Precinct.
The data generated from Nucleus Network is used to support IND and NDA regulatory filings for the USA FDA. Data is also used for EMA, PMDA and Health Canada regulatory filings.
In excess of
Phase 1 clinical trials conducted
years’ experience conducting Phase 1 clinical trials
Phase 1 clinical trial beds
Access to over
total population across Brisbane and Melbourne (Australia)
As well as
total population across Minneapolis – Saint Paul (USA)
sponsor audits, including FDA and EMA regulatory inspections